Prescription Antipyretics to Decrease Unscheduled Return Visits In A Pediatric Emergency Department

Part of paid clinical trials in Austin, Texas.

Sponsor
University of Texas at Austin
Study ID
NCT07074912
Status
Recruiting
Apply to this trial

Conditions

  • Fever

Eligibility Criteria

Sex
ALL
Age
6 Months - 36 Months
Healthy Volunteers
Not accepted

Interventions

  • Prescription for weight-based dosing of antipyretic — OTHER
    The intervention group (n=220) will receive prescription with weight-based dosing for acetaminophen (also prescribed and known as Tylenol) and ibuprofen (also prescribed and known as Motrin).
  • Standard discharge instructions — OTHER
    The control group (n=220) will also receive standardized printed discharge instructions but no prescription. The discharge instructions include the appropriate dose of acetaminophen (also known as Tylenol) and ibuprofen (also known as Motrin).

Study Details

The study aims to evaluate whether unscheduled return visits within one week for similar complaints are impacted by ensuring parents leave the emergency department (ED) with a prescription for appropriately dosed acetaminophen and ibuprofen for their child.

Key Dates

Start date
Dec 15, 2024
Status verified
Jul 2025
Primary completion
Dec 31, 2025
Completion
Mar 15, 2026

Study Design

Enrollment
440 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Prescription for weight-based dosing of antipyretic
    The intervention group (n=220) will receive prescription with weight-based dosing for acetaminophen (also known and prescribed as Tylenol) and ibuprofen (also known and prescribed as Motrin).
  • Active Comparator: Standard discharge instructions
    The control group (n=220) will also receive standardized printed discharge instructions, which includes the appropriate dose of acetaminophen (also known as Tylenol) and ibuprofen (also known as Motrin) but no prescription.

Primary Outcome Measure

Unscheduled return visits [ Time Frame: 7 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Dell Children's Medical CenterAustinTexas78723
Medical Director, MD
[email protected]
512-324-0000
Bradley Yingst, DO (PRINCIPAL_INVESTIGATOR)

Find similar trials in Austin, TX

By research site
Dell Children's Medical Center· Austin, TX

Related Studies